atai Life Sciences a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced first quarter 2024 financial results, provided corporate updates and announced a transition in its leadership.
atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates
Previous
Previous
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
Next
Next